| Title |
Clinical features and risk factors for upper gastrointestinal bleeding in children: a case-crossover study
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, May 2010
|
| DOI | 10.1007/s00228-010-0832-3 |
| Pubmed ID | |
| Authors |
Lamiae Grimaldi-Bensouda, Lucien Abenhaim, Laurent Michaud, Olivier Mouterde, Annie Pierre Jonville-Béra, Bruno Giraudeau, Benoît David, Elisabeth Autret-Leca |
| Abstract |
This population-based survey was conducted to provide a formal description of upper gastrointestinal bleeding (UGIB) in children on a nationwide basis and assess the contribution of risk factors, principally nonsteroidal anti-inflammatory drugs (NSAID). |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 1 | 2% |
| Canada | 1 | 2% |
| Unknown | 55 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 11 | 19% |
| Researcher | 10 | 18% |
| Student > Postgraduate | 7 | 12% |
| Student > Doctoral Student | 3 | 5% |
| Librarian | 2 | 4% |
| Other | 9 | 16% |
| Unknown | 15 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 49% |
| Biochemistry, Genetics and Molecular Biology | 2 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
| Unspecified | 2 | 4% |
| Environmental Science | 1 | 2% |
| Other | 4 | 7% |
| Unknown | 18 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2022.
All research outputs
#2,439,709
of 23,299,593 outputs
Outputs from European Journal of Clinical Pharmacology
#171
of 2,590 outputs
Outputs of similar age
#9,089
of 96,374 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#3
of 13 outputs
Altmetric has tracked 23,299,593 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,590 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,374 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.